Costs of excessive postoperative hemorrhage in cardiac surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 138, Issue 3, 2009, Pages 687-693

  Christensen, Michael C ^a   Krapf, Stephan ^b   Kempel, Angela ^c   von Heymann, Christian ^d  

^a NOVO NORDISK A S   (Denmark)

^b Klinik fur Herzchirurgie   (Germany)

^c Pharmametrics GmbH   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; FEMALE; HEALTH CARE PLANNING; HEART SURGERY; HOSPITAL COST; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RISK FACTOR;

AGED; CARDIAC SURGICAL PROCEDURES; COSTS AND COST ANALYSIS; FEMALE; GERMANY; HOSPITAL COSTS; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE HEMORRHAGE; QUALITY ASSURANCE, HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 68949169364     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.02.021     Document Type: Article

References (22)

1. Bucerius J., Gummert J.F., Borger M.A., Walther T., Doll N., Onnasch J.F., et al. Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg 75 (2003) 472-478
2. Hall T.S., Brevetti G.R., Skoultchi A.J., Sines J.C., Gregory P., and Spotnitz A.J. Re-exploration for hemorrhage following open heart surgery differentiation on the causes of bleeding and the impact on patient outcomes. Ann Thorac Cardiovasc Surg 7 (2001) 352-357
3. Moulton M.J., Creswell L.L., Mackey M.E., Cox J.L., and Rosenbloom M. Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Cardiovasc Surg 111 (1996) 1037-1046
4. Dacey L.J., Munoz J.J., Baribeau Y.R., Johnson E.R., Lahey S.J., Leavitt B.J., et al. Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group. Arch Surg 133 (1998) 442-447
5. Karkouti K., Wijeysundera D.N., Yau T.M., Beattie W.S., Abdelnaem E., McCluskey S.A., et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 44 (2004) 1453-1462
6. Murphy G.J., Reeves B.C., Rogers C.A., Rizvi S.I., Culliford L., and Angelini G.D. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 116 (2007) 2544-2552
7. Herwaldt L.A., Swartzendruber S.K., Zimmerman M.B., Scholz D.A., Franklin J.A., and Caldarone C.A. Hemorrhage after coronary artery bypass graft procedures. Infect Control Hosp Epidemiol 24 (2003) 44-50
8. Herwaldt L.A., Swartzendruber S.K., Edmond M.B., et al. The epidemiology of hemorrhage related to cardiothoracic operations. Infect Control Hosp Epidemiol 19 (1998) 9-16
9. Daly D.J., Myles P.S., Smith J.A., Knight J.L., Clavisi O., Bain D.L., et al. Anticoagulation, bleeding and blood transfusion practices in Australasian cardiac surgical practice. Anaesth Intensive Care 35 (2007) 760-768
10. Whitlock R., Crowther M.A., and Ng H.J. Bleeding in cardiac surgery: its prevention and treatment-an evidence-based review. Crit Care Clin 21 (2005) 589-610
11. Charalambous C.P., Zipitis C.S., and Keenan D.J. Chest reexploration in the intensive care unit after cardiac surgery: a safe alternative to returning to the operating theater. Ann Thorac Surg 81 (2006) 191-194
12. Koch C.G., Li L., Duncan A.I., Mihaljevic T., Cosgrove D.M., Loop F.D., Starr N.J., and Blackstone E.H. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 34 (2006) 1608-1616
13. Engoren M.C., Habib R.H., Zacharias A., Schwann T.A., Riordan C.J., and Durham S.J. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 74 (2002) 1180-1186
14. BQS Bundesgeschäftsstelle Qualitätssicherung. BQS-Qualitätsreport 2006. Available at: http://www.bqs-qualitaetsreport.de. Last accessed February 2008.
15. Lee W.C., Christensen M.C., Joshi A., and Pashos C. Long-term cost of stroke sub-types among Medicare beneficiaries. Cerebrovasc Dis 23 (2007) 57-65
16. Sloss E.M., Wickstrom S.L., McCaffrey D.F., Garber S., Rector T.S., Levin R.A., et al. Direct medical costs attributable to acute myocardial infarction and ischemic stroke in cohorts with atherosclerotic conditions. Cerebrovasc Dis 18 (2004) 8-15
17. Navarrete P., Hart W.M., Lopez J., and Christensen M.C. The societal costs of intracerebral haemorrhage in Spain. Eur J Neurol 14 (2007) 556-562
18. Karthik S., Grayson A.D., McCarron E.E., Pullan D.M., and Desmond M.J. Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay. Ann Thorac Surg 78 (2004) 527-534
19. Sellman M., Intonti M.A., and Ivert T. Reoperations for bleeding after coronary artery bypass procedures during 25 years. Eur J Cardiothorac Surg 11 (1997) 521-527
20. Herzchirurgie, Bad Krozingen. Herzchirurgie, Bad Krozingen-DRG-Entgelttarif 2007 für Krankenhäuser im Anwendungsbereich des KHEntG. Bad Krozingen: Herzzentrum; 2007. p. 2008.
21. Harig F., Rösch J., Mahmoud F.O., Weyand M., and Feyrer R. Cost effectiveness of routine antifibrinolytic therapy in cardiac surgery: tranexamic acid shows equivalent effects and reduces costs compared to aprotinin. [abstract]. Thorac Cardiovasc Surg 55 (2007)
22. Graf J., Graf C., and Janssens U. Analysis of resource use and cost-generating factors in a German medical intensive care unit employing the Therapeutic Intervention Scoring System (TISS-28). Intensive Care Med 28 (2002) 324-331